ALX Oncology Holdings Inc.

NASDAQ:ALXO

2.17 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -39.399-35.581-45.472-50.99-34.159-30.184-30.709-35.32-32.92-24.533-28.438-24.566-16.274-14.185-18.774-10.181-11.331-5.454-7.764-3.044-4.197-4.238
Depreciation & Amortization 0.220.2140.2070.2090.2070.2130.1050.0950.0840.0580.0340.0060.0060.0050.0050.0050.0790.1130.1120.1110.1090.097
Deferred Income Tax 00-11.619-1.842-1.650000000000.6210.2420.3080.10000
Stock Based Compensation 7.2527.0316.7216.9646.2376.3516.2956.2075.8365.5015.6864.1912.2371.81.7430.6892.8530.1510.0750.0860.060.076
Change In Working Capital 6.21-8.5580.33114.128-2.714-3.4483.973-1.8089.81-2.1250.266-4.743-6.7377.1872.708-0.2951.815-3.9814.692-0.339-0.30.204
Accounts Receivables 000000000000000.53600.001-0.0010.00100.001-0.001
Change In Inventory 000000000000003.6020000000
Change In Accounts Payables 1.883-2.326-4.4848.886-5.7111.7672.454-3.0643.5631.553-0.33-2.182-1.5447.346-1.421-0.32-0.242-1.7613.067-0.567-0.2450.721
Other Working Capital 4.327-6.2324.8155.2422.997-1.7671.5191.2566.247-3.6780.596-2.561-5.193-0.159-0.0090.0252.057-2.221.6250.228-0.055-0.517
Other Non Cash Items 4.968.75510.1540.3720.368-0.748-0.332-0.0570.1920.4254.9640.2560.1460.0580.082-0.0080.1130.1080.011-0.001-00.001
Operating Cash Flow -26.566-37.924-39.678-31.159-31.711-27.816-20.668-30.883-16.998-20.674-17.488-24.856-20.622-5.135-13.615-9.548-6.163-8.963-2.874-3.186-4.328-3.861
Investing Activities:
Investments In Property Plant And Equipment -0.09-0.148-0.1481.303-1.739-0.69-0.389-0.192-0.257-0.589-4.518-0.3980-0.007-0.011-0.010-0.010.0620-0.297-0.118
Acquisitions Net 000.0510-0.008-0.043-0.011-0.0140.0760000000000000
Purchases Of Investments -62.964-31.285-75.01-52.889-46.526-72.204-60.969-36.613-95.875-183.332000000000000
Sales Maturities Of Investments 63.96157.90658.49264.40154.478115.18972.350.5200000000000000
Other Investing Activites 00.027-0.0170.0120.0080.0430.0110.014-0.076-0.183-4.25700000.641000000
Investing Cash Flow 0.90726.473-16.66612.8156.21342.29510.94213.695-76.132-183.921-4.518-0.3980-0.007-0.0110.6310-0.010.0620-0.297-0.118
Financing Activities:
Debt Repayment -0.218-0.175-0.063-0.111-0.107-0.107-9.238-0.141-0.035-0.105-0.104-0.104-0.0730-0.0470000000
Common Stock Issued 27.373.26159.22900.4500.2560.0050.4570.1850.6280.5430.8040.778368.2560000000
Common Stock Repurchased 000.5230000.3360000.202000-179.280000000
Dividends Paid 00000000000000-0.0030000000
Other Financing Activities 00.0030.0590000.010000.0010.0010.0010.001-0.565170.298-0.769104.9915.92709.430
Financing Cash Flow 27.1523.08659.166-0.1110.343-0.1079.494-0.1360.4220.080.5240.4390.7310.778188.361170.298-0.769104.9915.92709.430
Other Information:
Effect Of Forex Changes On Cash 00-50.40722.18328.22400000000000000000
Net Change In Cash 1.493-8.3652.822-18.455-25.15514.372-0.232-17.324-92.708-204.515-21.482-24.815-19.891-4.364174.735161.381-6.93296.0183.115-3.1864.805-3.979
Cash At End Of Period 15.53414.04122.40619.6538.10563.2648.88849.1266.444159.152363.667385.149409.964429.855434.219259.48498.103105.0359.0175.9029.0884.283